The Circadian Gene Per1 Plays an Important Role in Cell Growth and DNA Damage Control in Human Cancer Cells

Molecular Cell

Volumn 22, Issue 3, 2006, Pages 375-382

  Gery, Sigal ^a   Komatsu, Naoki ^a   Baldjyan, Lilit ^a   Yu, Andrew ^a   Koo, Danielle ^a   Koeffler, H Phillip ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; CHECKPOINT KINASE 2;

APOPTOSIS; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CANCER INHIBITION; CARCINOGENESIS; CELL CYCLE; CELL FUNCTION; CELL GROWTH; CIRCADIAN RHYTHM; DNA DAMAGE; GENE; GENE OVEREXPRESSION; GROWTH REGULATION; HUMAN; HUMAN CELL; PER1 GENE; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN INTERACTION; REGULATORY MECHANISM;

APOPTOSIS; CDC2 PROTEIN KINASE; CELL CYCLE PROTEINS; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CIRCADIAN RHYTHM; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; DNA DAMAGE; DOWN-REGULATION; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HCT116 CELLS; HUMANS; NEOPLASMS; NUCLEAR PROTEINS; PROTEIN BINDING; PROTEIN-TYROSINE KINASES; RADIATION, IONIZING; RNA, MESSENGER; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 33646084831     PISSN: 10972765     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molcel.2006.03.038     Document Type: Article

References (35)

1. Abraham R.T., and Tibbetts R.S. Cell biology. Guiding ATM to broken DNA. Science 308 (2005) 510-511
2. Adhikary S., and Eilers M. Transcriptional regulation and transformation by Myc proteins. Nat. Rev. Mol. Cell Biol. 6 (2005) 635-645
3. Ahn J., and Prives C. Checkpoint kinase 2 (Chk2) monomers or dimers phosphorylate Cdc25C after DNA damage regardless of threonine 68 phosphorylation. J. Biol. Chem. 277 (2002) 48418-48426
4. Barlow C., Eckhaus M.A., Schaffer A.A., and Wynshaw-Boris A. Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat. Genet. 21 (1999) 359-360
5. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., and Vogelstein B. Requirement for p53 and p21 to sustain G2 arrest after DNA damage. Science 282 (1998) 1497-1501
6. Chen C.R., Wang W., Rogoff H.A., Li X., Mang W., and Li C.J. Dual induction of apoptosis and senescence in cancer cells by Chk2 activation: checkpoint activation as a strategy against cancer. Cancer Res. 65 (2005) 6017-6021
7. Chen S.T., Choo K.B., Hou M.F., Yeh K.T., Kuo S.J., and Chang J.G. Deregulated expression of the PER1, PER2 and PER3 genes in breast cancers. Carcinogenesis 26 (2005) 1241-1246
8. Filipski E., Innominato P.F., Wu M., Li X.M., Iacobelli S., Xian L.J., and Levi F. Effects of light and food schedules on liver and tumor molecular clocks in mice. J. Natl. Cancer Inst. 97 (2005) 507-517
9. Fu L., Pelicano H., Liu J., Huang P., and Lee C. The circadian gene Period2 plays an important role in tumor suppression and DNA damage response in vivo. Cell 111 (2002) 41-50
10. Gery S., Gombart A.F., Yi W.S., Koeffler C., Hofmann W.K., and Koeffler H.P. Transcription profiling of C/EBP targets identifies Per2 as a gene implicated in myeloid leukemia. Blood 106 (2005) 2827-2836
11. Hansen J. Light at night, shiftwork, and breast cancer risk. J. Natl. Cancer Inst. 93 (2001) 1513-1515
12. Iliakis G., Wang Y., Guan J., and Wang H. DNA damage checkpoint control in cells exposed to ionizing radiation. Oncogene 22 (2003) 5834-5847
13. Kastan M.B., and Bartek J. Cell-cycle checkpoints and cancer. Nature 432 (2004) 316-323
14. Lee C.C. The circadian clock and tumor suppression by Mammalian period genes. Methods Enzymol. 393 (2005) 852-861
15. Lowrey P.L., and Takahashi J.S. Mammalian circadian biology: elucidating genome-wide levels of temporal organization. Annu. Rev. Genomics Hum. Genet. 5 (2004) 407-441
16. Mateyak M.K., Obaya A.J., and Sedivy J.M. c-Myc regulates cyclin D-Cdk4 and -Cdk6 activity but affects cell cycle progression at multiple independent points. Mol. Cell. Biol. 19 (1999) 4672-4683
17. Matsuo T., Yamaguchi S., Mitsui S., Emi A., Shimoda F., and Okamura H. Control mechanism of the circadian clock for timing of cell division in vivo. Science 302 (2003) 255-259
18. Panda S., Antoch M.P., Miller B.H., Su A.I., Schook A.B., Straume M., Schultz P.G., Kay S.A., Takahashi J.S., and Hogenesch J.B. Coordinated transcription of key pathways in the mouse by the circadian clock. Cell 109 (2002) 307-320
19. Pelengaris S., Khan M., and Evan G. c-MYC: more than just a matter of life and death. Nat. Rev. Cancer 2 (2002) 764-776
20. Pogue-Geile K.L., Lyons-Weiler J., and Whitcomb D.C. Molecular overlap of fly circadian rhythms and human pancreatic cancer. Cancer Lett. (2006) 10.1016/j.canlet.2005.11.049 in press. Published online January 29, 2006
21. Reddy A.B., Wong G.K., O'Neill J., Maywood E.S., and Hastings M.H. Circadian clocks: neural and peripheral pacemakers that impact upon the cell division cycle. Mutat. Res. 574 (2005) 76-91
22. Reppert S.M., and Weaver D.R. Coordination of circadian timing in mammals. Nature 418 (2002) 935-941
23. Sancar A., Lindsey-Boltz L.A., Unsal-Kacmaz K., and Linn S. Molecular mechanisms of mammalian DNA repair and the DNA damage checkpoints. Annu. Rev. Biochem. 73 (2004) 39-85
24. Schernhammer E.S., Laden F., Speizer F.E., Willett W.C., Hunter D.J., Kawachi I., Fuchs C.S., and Colditz G.A. Night-shift work and risk of colorectal cancer in the nurses' health study. J. Natl. Cancer Inst. 95 (2003) 825-828
25. Schibler U., and Sassone-Corsi P. A web of circadian pacemakers. Cell 111 (2002) 919-922
26. Seoane J., Le H.V., and Massague J. Myc suppression of the p21(Cip1) Cdk inhibitor influences the outcome of the p53 response to DNA damage. Nature 419 (2002) 729-734
27. Shearman L.P., Sriram S., Weaver D.R., Maywood E.S., Chaves I., Zheng B., Kume K., Lee C.C., van der Horst G.T., Hastings M.H., and Reppert S.M. Interacting molecular loops in the mammalian circadian clock. Science 288 (2000) 1013-1019
28. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat. Rev. Cancer 3 (2003) 155-168
29. Stark G.R., and Taylor W.R. Analyzing the G2/M checkpoint. Methods Mol. Biol. 280 (2004) 51-82
30. Storch K.F., Lipan O., Leykin I., Viswanathan N., Davis F.C., Wong W.H., and Weitz C.J. Extensive and divergent circadian gene expression in liver and heart. Nature 417 (2002) 78-83
31. Unsal-Kacmaz K., Mullen T.E., Kaufmann W.K., and Sancar A. Coupling of human circadian and cell cycles by the timeless protein. Mol. Cell. Biol. 25 (2005) 3109-3116
32. Vogelstein B., Lane D., and Levine A.J. Surfing the p53 network. Nature 408 (2000) 307-310
33. Yagita K., Yamaguchi S., Tamanini F., van Der Horst G.T., Hoeijmakers J.H., Yasui A., Loros J.J., Dunlap J.C., and Okamura H. Dimerization and nuclear entry of mPER proteins in mammalian cells. Genes Dev. 14 (2000) 1353-1363
34. Yeh K.T., Yang M.Y., Liu T.C., Chen J.C., Chan W.L., Lin S.F., and Chang J.G. Abnormal expression of period 1 (PER1) in endometrial carcinoma. J. Pathol. 206 (2005) 111-120
35. Zindy F., Eischen C.M., Randle D.H., Kamijo T., Cleveland J.L., Sherr C.J., and Roussel M.F. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. Genes Dev. 12 (1998) 2424-2433